Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma

This study has been completed.
Information provided by (Responsible Party):
National Cancer Institute (NCI) Identifier:
First received: September 19, 2006
Last updated: October 7, 2013
Last verified: October 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)